Literature DB >> 29699508

Factors associated with congenital anomalies in Addis Ababa and the Amhara Region, Ethiopia: a case-control study.

Molla Taye1, Mekbeb Afework2, Wondwossen Fantaye3, Ermias Diro4, Alemayehu Worku5.   

Abstract

BACKGROUND: The early stage of embryo development is extremely vulnerable to various teratogenic factors, leading to congenital anomalies. In Ethiopia, a significant number of babies are born with congenital anomalies, but the risk factors for the anomalies have never been studied. Understanding the specific risk factors for congenital anomalies is very essential to provide health education that aims at creating awareness and establishing preventive strategic plan/s. The main objective of this study was to assess the risk factors associated with congenital anomalies in Addis Ababa and the Amhara Region, Ethiopia.
METHODS: A case-control study was conducted from January 1- June 30, 2015. The participants were recruited at the purposively selected hospitals in Addis Ababa and the Amhara Region. A total of 207 cases and 207 controls were included in the study. Cases were neonates, infants, and children 0-11 months of age with external and internal major congenital anomalies diagnosed by pediatricians. Controls were neonates, infants, and children 0-11 months of age without external and internal anomalies. Data on sociodemographic characteristics, exposure to risk factors, and reproductive history were collected by face to face interviews with children's mothers/caregivers using a structured questionnaire. Binary logistic regression was employed to explore risk factors associated with the occurrence of the problems.
RESULTS: About 87.4% of the children were below 6 months, and 12.6% were between 6 and 11 months. The majority (59.9%) of the children were male, with the M: F sex ratio of 1.49. The mean age of the mothers was 26 years (16-45 years). Unidentified medication use during early pregnancy (AOR = 4.595; 95% CI: 1.868-11.301, P-value = 0.001), maternal alcohol drinking (AOR = 2.394; 95% CI: 1.212-4.726, P-value = 0.012), and exposure to chemicals (AOR = 9.964; 95% CI = 1.238-80.193, P-value = 0.031) were significantly associated with the occurrence of congenital anomalies. Iron folate use (AOR = 0.051; 95% CI: 0.010-0.260, P-value = < 0.001) before and during early pregnancy had a protective effect on congenital anomaly.
CONCLUSION: Unidentified medication use, alcohol drinking during early pregnancy, and exposure to chemicals had a significant association with the occurrence of congenital anomalies, whereas iron folate use before and during early pregnancy had a protective effect from congenital anomalies.

Entities:  

Keywords:  Case-control; Congenital anomaly; Risk/Associated factors; Teratogen

Mesh:

Substances:

Year:  2018        PMID: 29699508      PMCID: PMC5921791          DOI: 10.1186/s12887-018-1096-9

Source DB:  PubMed          Journal:  BMC Pediatr        ISSN: 1471-2431            Impact factor:   2.125


Background

The early stages of embryo development are a critical period which may mark vulnerability to disruption by teratogenic agents that lead to congenital anomaly [1-3]. Congenital anomaly (CA) is defined as a structural or functional defect that may be detected during pregnancy or be visible at birth or later in life. CAs are the major cause of new born/infant morbidity, mortality, and disability in addition to adding to the burden of the health care system [4]. It is estimated that about 20–30% of infant deaths occur due to CAs [5]; severe CAs occur in 3% of live [6, 7], and 20% of still births [8], and 7.9 million children are born with serious CAs, accounting for 6% of all births globally [9]. According to literature, genetic and environmental factors play a major role in causing CAs during the first trimester [10]. Approximately, 7.6 million children are born with CAs worldwide due to genetic factors [11]. Although there is a better understanding of the etiology of CA in the literature, the causes of most of the CAs are still unknown. However, they are believed to be caused by several etiologic factors [12, 13]. The occurrence of certain risk factors, such as maternal chronic diseases, like diabetes, family history, and viral infections during early pregnancy increase the risk of having a baby with CAs [14-17]. Furthermore, risk factors linked to the occurrence of CAs include unidentified medication/illicit/prescribed drug/s use, alcohol consumption, smoking cigarettes, exposure to radiation, chemical agents, parental age, parental occupation, nutritional deficiencies, and chromosomal mutations as well as socio-economic factors [7, 14, 15, 18–20]. Hence, exposure to all of these factors can influence the organogenesis processes of the embryo [7, 12]. Moreover, some studies showed that maternal use of folic acid and multivitamins containing folic acid around conception and the first 3 months of pregnancy have a protective effect against certain types of CAs [21, 22]. In general, the prevalence of CAs varies with race, ethnicity, and geographical regions across the world [7, 11, 16, 23, 24]. In Ethiopia, a significant number of babies are born with CAs, but the causes of these CAs have never been studied. In fact, whether the causes are environmental or genetic factors or interactions between environmental and genetic factors are not known. In addition, there are no preventive strategic plans to reduce or control the occurrence of these problems. It is obvious that children born with major CA are prone to die or even if they survive, they may confront a long-term morbidity and disability and may also undergo repeated surgical interventions. Evidence based information about specific risk factors for CAs are very essential to provide health education to communities, especially to females in the reproductive age. This could not only help to create awareness so as to reduce the occurrence of anomalies but also assists policy makers/responsible bodies to develop preventive strategic plans. The main objective of this study was to assess the risk factors for CAs in Addis Ababa and the Amhara Region. The results are believed to provide information for public health actions and to create awareness about CAs and their etiologic factors. They may also be used as baseline for further investigations.

Methods

Study sites

The study was carried out in Addis Ababa and the Amhara region, Ethiopia. Addis Ababa, the capital of Ethiopia, has 10 sub-cities with an estimated total population of 3,273,001(47.4% male, 52.6% female). The population of Addis is diverse by ethnicity. The majority of the people are Christians, followed by Muslims and some followers of other religions [25]. The city is subject to population increase through continuous migrations [25]. All of the hospitals in the city provide inpatient, outpatient, and delivery services, except Cure Ethiopia International Children’s Hospital, which does not provide delivery services. The Amhara Region, the second largest northwest region of the country has a population of 20,399,004 (50.1% male, 49.9% female). The majority of the people live in rural areas and the minority in large and small towns. Most of the Amhara people are Christians, with a good number of Muslims and some followers of other faiths [25]. All of the hospitals in the regional state provide various inpatient and outpatient services including delivery.

Selection of study hospitals

Five public hospitals in Addis Ababa and three in the Amhara Region were purposively selected for this study on the basis of case load. All of the hospitals are referral with high patient flow and various specialized departments or units, which provide various services to neonates, infants, children, and adults.

Study design and sample size

A case-control design was used to investigate exposure status to risk factors for CAs in the case and control children. A sample of 414 children (207 cases, 207 controls) was recruited for this study. The sample size was calculated by using a ratio of 1:1, power of 90%, a 5% significance level and 38.81% of likelihood of an event in controls (i.e. exposure in controls) [17], and assuming the Odds ratio to be 2. The study children were matched by age. Cases were neonates, infants, and children 0-11 months of age with external and internal major CAs. Major CAs are defined as anomalies that have partial or complete organ/organ system absence/defects, resulting in functional, health, and cosmetic effects, which require surgical repair and rehabilitations [4]. The cases were selected from live births at the study hospitals, neonate units and under five clinics. The type of CAs were classified as major by using WHO/CDC/ICBDSR manual 2014 [4]. Based on WHO/CDC/ICBDSR classification method, the cases with neural tube, orofacial region, musculoskeletal system and genitourinary system defects and less than 12 months of age were purposively selected and included in the study. Children aged 12 months and above and had major and minor CA were excluded. All cases had isolated CAs except one child who had multiple anomalies. The diagnoses of the cases were confirmed through physical examinations and echocardiography (i.e. for cases with heart defects) by pediatricians. The cases were selected purposively. The controls were neonates, infants, and children 0-11 months of age without external and internal CAs. The controls were randomly selected in the same hospitals where children with CAs were identified. All children aged 0-11 months constituted the source population.

Data collection method

The data were collected by a face to face interview of the children’s mothers/caregivers by using a structured questionnaire and checklists. The questionnaire prepared in English and translated to Amharic was pretested at other hospitals and amended according to the results. Data were collected on residence, sociodemographic characteristics, reproductive/pregnancy history and adverse outcomes, family history of CAs, socio-economic status, parental ethnicity, parental occupation, maternal educational level, maternal nutritional status/history, parental exposures to risk factors and/or teratogenic agents, such as radiation, chemicals, pesticides, etc. for CAs, maternal illness/disease, medication/illicit drug use, substance abuse (alcohol consumption, smoking), blood relationships among parents, antenatal care visits, folic acid and multivitamin use, and birth order of children. The data were gathered at delivery rooms/wards, neonatal units, and under five clinics. Prior to data collection, data collectors (nurses, midwifes) were trained for 2 days. The data were collected from January 1- June 30, 2015.

Data management and analysis

Data were checked on daily basis by collectors and further overseen by the principal investigator and supervisors for completeness and correctness during collection periods. It was also rechecked during data entry. The data were coded and entered into Epi-Info version 3.5.1 and then transferred to SPSS version 21 for analysis. Data cleaning, error checking, and analysis were conducted by using SPSS version 21. Data were calculated by using frequency, cross tabulation, and binary logistic regression. Significance level was considered at less than 0.05 p-value. Crude Odds ratio and confidence level were calculated. After the crude Odds ratios were identified, adjusted Odds ratios were computed to assess risk factors associated with the occurrence of CAs by using backward stepwise logistic regression. Exposure variables with P-value ≤0.2 in the crude Odds ratio were entered into the multivariable logistic regression model to observe their relationships and CAs (i.e. to observe associated variables with CAs in the adjusted Odds ratio). The characteristics of cases and controls were explained in percentages and numbers. The crude and adjusted Odds ratios, confidence intervals, p-values and the overall findings are presented in the result section in the form of texts and tables.

Ethical clearance

Ethical clearance was obtained from Addis Ababa University, College of Health Sciences Institutional Review Board, the National Research Ethics Review Committee, Addis Ababa City Administration Health Bureau Ethical Clearance Committee, and the Amhara National Regional State Health Bureau Regional Health Research Laboratory Center. Supportive letters were written to all zonal health departments and study hospitals by the health bureaus. Ethical and supportive letters were submitted to all hospital administrators. The purpose of the study was explained to the participant children’s mothers/caregivers. Data collection began after permissions were obtained from hospital managers/medical directors and after a written consent was obtained from children’s mothers/caretakers. Data collected from the participants were kept in secured and locked cabinets in order to maintain confidentiality.

Results

Socio-demographic characteristics of the study participants

The sample consisted of 414 (207 cases, 207 controls) children. The age of children ranged from 1 day to 11 months. About 87.4% of the children were below 6 months and 12.6% between 6 and 11 months. The majority (59.9%) of the children were male and 40.1% female with a sex ratio of 1.49, respectively. The mean age of the children’s mothers was 26 years (range 16-45). Among the participants, 63.3% were urban and 36.7% rural dwellers. In terms of income, 47.8% had middle and 37.2% low economic status as stated by the mothers/respondents. The majority (93.5%) of the children’s mothers were married; about 37.4% had no formal education; 31.9% had primary education, and 30.7% secondary and higher level of education. By religious affiliation, 72.2, 27.3, and 0.5% of the parents were Christian, Muslim, and others, respectively. Among the mothers, 53% were housewives, 17.9% government, private, or self-employed, 14.3% farmers, and 14% jobless. Similarly, 49.3, 38.9, and 11.8% of the children’s fathers were employees, farmers, and jobless, respectively. The major (62.1%) ethnic group in this study were Amhara, 23.2% Oromo, 5.6% Guragie, 3.6% Tigre, and 3.6% Seltie. The other socio-demographic characteristics of the participants are shown in Table 1.
Table 1

The socio-demographic characteristics of the study participants, Addis Ababa and the Amhara Region, Ethiopia, 2016

CharacteristicsCases (n = 207)Controls (n = 207)Total (n = 414)
Frequency%Frequency%Frequency%
Study SiteAddis Ababa10651.210751.721351.4
Amhara Region10148.810048.320148.6
Infant/Child AgeBelow 6 months18187.418187.436287.4
6-11 months2612.62612.65212.6
Infant/Child SexMale12359.412560.424859.9
Female8440.68239.616640.1
Child Mother Age< 20 years115.3115.3225.3
20-34 years16780.716981.633681.2
> 34 years2914.02713.05613.5
Child Mother Marital statusMarried19091.819795.238793.5
Never married178.2104.8276.5
ReligionChristian13967.116077.329972.2
Muslim6631.94722.711327.3
Other21.00020.5
Child Mother EducationNo education10148.85426.115537.4
Primary5928.57335.313231.9
Secondary and higher4722.78038.612730.7
Monthly incomeRegular8440.67435.715838.2
Irregular12359.413364.325661.8
Child Mother EthnicityOromo6330.43315.99623.2
Amhara12258.913565.225762.1
Guragie73.4178.2245.8
Othersa157.32210.6378.7
Child Mother OccupationHouse wife12258.910148.822353.9
Employed2813.54622.27417.9
Farmer/Agriculture3215.52713.05914.3
No job/unemployed2512.13315.95814.0
ResidenceUrban9746.916579.726263.3
Rural11053.14220.315236.7
Economic StatusLow8943.06531.415437.2
Middle10048.39847.319847.8
higher188.74421.36215.0
Child Father EthnicityOromo6330.43315.99623.2
Amhara1165613364.324960.1
Guragie83.9157.2235.6
Othersa209.62612.64610.9
Child Father OccupationEmployed7234.813263.820449.3
Farmer/Agriculture10751.75426.116138.9
No job/unemployed2813.52110.14911.8
Region originatedAmhara10651.210148.820750.0
Oromia4521.7188.76315.2
Addis Ababa3516.98038.611527.8
Other regions b2110.383.9297.0

aOthers = Tigre, Somali, Afar, Seltie, Benishangul, Agew, Gamo, Hadya, Argob

bOther regions = Southern Nations Nationalities and People, Tigray, Afar, Benishangul-Gumuz, Harari, Dire Dawa

The socio-demographic characteristics of the study participants, Addis Ababa and the Amhara Region, Ethiopia, 2016 aOthers = Tigre, Somali, Afar, Seltie, Benishangul, Agew, Gamo, Hadya, Argob bOther regions = Southern Nations Nationalities and People, Tigray, Afar, Benishangul-Gumuz, Harari, Dire Dawa About 12 (5.8%) and 13 (6.3%) of mothers whose children had and had no CAs, respectively, were in the 15-19 years of age group. Besides, 49 (23%) and 68 (32.9%) of mothers whose children were exposed and not exposed to CAs, respectively, were 20-24 years of age. Similarly, 69 (33.3%) and 68 (32.9%) of the mothers who had children with and without CAs, respectively, were in the 25–29 years of age group, whereas 49 (23.7%) and 31 (15%) mothers who had and free children, respectively, were in the 30–34 years of age group. Likewise, 28 (13.5%) and 27 (13%) of the mothers who had affected and non-affected children, respectively, were 35–39 years of age. About 99.5% of the CAs identified were isolated/single, while 1 (0.5%) was multiple. The frequency of CAs by organ/organ system is shown in Table 2.
Table 2

Frequency of congenital anomalies by organ/organ system among the study subjects, Addis Ababa and the Amhara Region, Ethiopia, 2016

Type of Congenital Anomaliesfrequency%
Neural Tube Defects (Spina bifida with and without hydrocephaly, clubfoot; encephalocele (occipital, frontal, and nasal))12430
Orofacial Clefts (cleft lip, cleft lip and palate, and cleft palate)5413
Masculoskeletal Defects (reduction defects of tibia, femur, ulna, and radial bones, talipes equinovarus, tracheoesophageal fistula, gastroschisis, and amelia of upper limb)204.8
Heart Defects (ventricular septal defects)51.2
Genitourinary Anomalies (hypospadias with sub-coronal and penile)30.7
Bladder extrusion with cleft lip and palate10.2
No Congenital Anomalies/Controls20750
Total414100
Frequency of congenital anomalies by organ/organ system among the study subjects, Addis Ababa and the Amhara Region, Ethiopia, 2016

Reproductive, obstetric, and offspring background/history

As far as the birth order of children was concerned, 32.9, 19.8, and 47.3% were first, second, third and above (3+) children to their families, respectively. Among the controls, about 48.3, 22.7, and 29% were first, second, third and above (3+) children, respectively, to their parents. About 16.4% of mothers whose children had CAs and 9.2% of the mothers who had children without CAs, had no antenatal care (ANC) visits. The total number of pregnancy history, preterm, miscarriage, stillbirth, gravidity, gestational age at first ANC, number of live births, and neonate/infant/child deaths are presented in Table 3.
Table 3

Reproductive history of the study participants/children’s mothers, Addis Ababa and the Amhara Region, Ethiopia, 2016

CharacteristicsCasesControlsTotal
(n = 207)%(n = 207)%(n = 414)%
Birth orderFirst6832.910048.316840.6
Second4119.84722.78821.3
Third and above9847.36029.015838.2
Total number of pregnancy16732.410048.316740.3
2-36933.37033.813933.6
4 and above7134.33717.910826.1
Full and post term pregnancyPost term125.852.4174.1
1-212459.916579.728969.8
3 and above7134.33717.910826.1
PretermNone15876.317886.033681.2
14722.72612.67317.6
2 and above21.031.451.2
Elective terminationNone18488.919996.138392.5
1-22311.183.9317.5
MiscarriageNone13163.317484.130573.7
1-27636.73115.010725.8
3 and above0021.020.5
Still birthNone16479.2319091.835485.5
1-24220.29178.25914.3
3 and above10.50010.2
Neonate/Infant/child deathNone17886.018991.336788.9
1-22914.0178.24611.1
3 and above0010.510.2
Living childrenNone73.40071.7
1-212962.316981.629872.0
3 and above7134.33818.410926.3
GravidityPrimigravida7033.810048.317041.1
Multigravida13766.210751.724458.9
Gestational age at 1st ANC (antenatal care) visitNo ANC visit3416.4199.25312.8
1-3 months2713.02914.05613.5
4 months and above14670.515976.830573.7
Institution for ANC attendedPublic hospital2713.02311.15012.1
Public health center13062.814771.027766.9
Private hospital62.941.9102.4
Private clinic73.4136.3204.8
Health post31.410.541.0
No ANC visit3416.4199.25312.8
Reproductive history of the study participants/children’s mothers, Addis Ababa and the Amhara Region, Ethiopia, 2016

Risk factors associated with congenital anomalies

There were maternal/medical illnesses (i.e. infections or chronic diseases such as diseases with fever, chronic disorders) in 24 (11.6%) of the mothers who had children with CAs and 13 (6.3%) of mothers whose children were not affected with CAs. Passive smokers were observed in 37 (17.9%) and 28 (13.5%) of mothers who had children with and without CAs, respectively. Among the participants, unidentified medication use in early pregnancy by mothers whose children had and had no CAs were 16.9 and 3.9%, respectively. Contraceptive (both pill and injection) use around conception was 11.6% in the mothers who had children with CAs and 2.4% in the mothers who had no children with CAs. In addition, anemia was observed in 55 (26.6%) of the affected children’s mothers and 37 (17.9%) of mothers whose children had no CAs (Table 4).
Table 4

Participant’s response on risk factors for congenital anomaly: Results from multivariable analysis-adjusted for substance abuse/behavioral, parental, and environmental factors, maternal illness, iron folate/folic acid, multivitamin, and vegetable use variables, Addis Ababa and the Amhara Region, Ethiopia, 2016

CharacteristicsCasesControlsCORAOR95% CIP-value
lowerupper
Number%Number%
Iron folate/folic acid useYes212210.60.0820.0510.0100.260< 0.001
No2059918589.41Ref
Unidentified medication useYes3516.983.95.0624.5951.86811.3010.001
No17283.119996.11
Drank alcohol (daily, occasionally and 1-3times in a week)Yes4923.7188.73.2562.3941.2124.7260.012
No15876.318991.31
Exp. to chemical (mother)Yes136.310.513.8049.9641.23880.1930.031
No19493.720699.51
Contraceptive useYes2411.652.45.2984.8401.64714.2240.004
No18388.420297.61
Blood relationship between child parentsYes104.8215.2036.2340.95940.5210.055
No19795.2205991
Family historyYes94.331.43.0913.3970.86213.3930.081
No1989520498.61
Vegetable ServingYes13967.116479.20.5360.6440.3921.0590.083
No6832.94320.81
Maternal illnessYes2411.6136.31.9572.0250.9034.540.087
No18388.419493.71
Exp. to radiation before conception (child father)Yes73.4213.5876.8380.74163.1090.090
No20096.6205991

Exp exposure, COR crude odds ratio, AOR adjusted odds ratio, CI confidence interval, Ref reference

Participant’s response on risk factors for congenital anomaly: Results from multivariable analysis-adjusted for substance abuse/behavioral, parental, and environmental factors, maternal illness, iron folate/folic acid, multivitamin, and vegetable use variables, Addis Ababa and the Amhara Region, Ethiopia, 2016 Exp exposure, COR crude odds ratio, AOR adjusted odds ratio, CI confidence interval, Ref reference Blood relationships among parents were reported in 4.8% of children’s the exposed mothers and 1.0% of not exposed children’s mothers. Family history of CA as seen in the children was also reported in 4.3% of the affected children’s parents and 1.4% of the parents whose children had no CAs. Exposure to chemicals among mothers who had children with and without CAs was 6.3 and 0.5%, respectively. On the other hand, two (0.97%) of mothers whose children had CAs used fertility enhancing drugs. Again, one (0.5%) of the affected child mother had diabetes during pregnancy. On the contrary, mothers who had children without CAs reported no use of fertility enhancing drugs around conception and had no diabetes during and before pregnancy. In addition, none of the affected children’s mothers took multivitamins before they got pregnant, while one (0.5%) of the mother who had child without CA used multivitamin before pregnancy. Moreover, about 25 (12.1%) of mothers whose children had CAs and 17 (8.2%) of the mothers who had children without CAs, had no food shortage before and during pregnancy (Table 4). However, the above-mentioned factors were not statistically significant in the multivariable analysis, the adjusted Odds Ratio. In addition, maternal age, parental ethnicity, mothers educational level, parental occupation (Table 1) and parity, birth order, preterm, still birth, and miscarriage (Table 3) were not statistically significant in the crude and adjusted Odds Ratio analysis. Thirteen variables were entered into the COR analysis. Of these, unidentified medication used during the first 3 months of gestation (COR = 5.062; 95% CI: 2.286-11.206, P-value = < 0.001), alcohol consumption during early/throughout pregnancy (COR = 3.256; 95% CI: 1.823-5.816, P-value = < 0.001), anemia during early pregnancy (COR = 1.663; 95% CI: 1.038-2.662, p-value = 0.034), contraceptive use around conception (COR = 5.298; 95% CI: 1.980- 14.175, P-value = 0.001), and chemical exposure during early pregnancy (COR = 13.804; 95% CI; 1.789-106.522, P-value = 0.012), and blood relation among parents (COR = 5.203; 95% CI:1.126-24.046, P-value = 0.035) were associated with CAs in the crude Odds ratio analysis. On the other hand, folic acid/iron folate (COR = 0.082; 95% CI: 0.019-.354, P-value = 0.001) and vegetable servings/use during early pregnancy (COR = 0.536; 95% CI: 0.344-0.835, P-value = 0.006) was protective against the occurrence of CAs (Table 4). However, vegetable serving was not associated with the occurrence of CAs in the adjusted Odds ratio analysis. Twelve variables (alcohol drinking, anemia, iron folate/folic acid, unidentified medication, contraceptive, exposure to chemicals, vegetable serving, blood relationship between child parents, exposure to radiation, maternal illness, family history, and food shortage during early pregnancy) whose value ended up with 0.2 and below in the crude Odds ratio were entered into the multivariable logistic regression model to observe exposure variables associated with CAs. As indicated in Table 4, unidentified medication use (AOR = 4.595; 95% CI: 1868-11.301, P-value = 0.001), maternal alcohol drinking in early pregnancy (AOR = 2.394; 95% CI: 1.212-4.726, P-value = 0.012), and exposure to chemicals during early pregnancy (AOR = 9.964; 95% CI: 1.238-80.193, P-value = 0.031) were significantly associated with the occurrence of CAs. On the contrary, iron folate/folic acid supplementation (use) before and during early pregnancy (AOR = 0.051; 95% CI: 0.010-0.260, P-value = < 0.001) had a protective effect against CA.

Discussion

According to our findings, unidentified medication use, alcohol consumption during early pregnancy or throughout pregnancy, and exposure to chemicals during early pregnancy had significant associations with the occurrence of CAs in this study, whereas iron folate supplementation before and during early pregnancy showed a protective effect against CA. Like our study, scientific literature reports that drug usage during pregnancy is associated with CAs [26-31]. In Ethiopia, drugs are being sold by private drug venders, stores, clinics, and some shops with and without prescriptions. This indicates that mothers are likely to use medications/over-the counter drugs during their early pregnancy. Therefore, responsible bodies should control over-the-counter. The association of alcohol drinking during and before early pregnancy and CA was also reported by Grewal et al., [32], Zhang et al., [33], and O’Leary et al., [34, 35]. In the liver, alcohol is metabolized into acetaldehyde, a toxic chemical/substance. To convert this toxic substance into a non-toxic and usable chemical, enzyme acetaldehyde dehydrogenases that secreted converts the acetaldehyde into acetic acid, which is useable by the body. However, when the unconverted acetaldehyde accumulates in the body, it causes irritation of the cells and tissues and then damages the cells and tissues, leading to metabolism and cellular growth abnormalities [36]. Moreover, alcohol is capable of crossing the placenta membrane and being carried to all developing cells and tissues of the embryo and fetus, and as a result causes damages to the developing tissues and cells and subsequently leads to a structural abnormality. Furthermore, alcohol drinking during pregnancy results in a serious consequences which manifest with recognized characteristics of physical and mental abnormal features after a baby is born [36-44]. In Ethiopia, alcohol is consumed by the community [45, 46], particularly locally made alcoholic beverages known as “areki” and “tella” in Amharic are consumed by both men and women in rural communities, especially among Christians, more specifically Orthodox Christians, across the country, whereas some urban dwellers, including women drink beer and other alcoholic drinks. In this study, women who consumed alcohol daily and women who took alcohol to an increasing degree had children with CAs. Therefore, health education is essential for the community, particularly women in the 15-49 years of age group. In the present study, exposure to chemicals had a significant association with CAs. Likewise, exposure to chemicals has been reported as having a significant association with the occurrence of CAs [47-51]. In this study, mothers of cases who reported maternal/medical illnesses during early pregnancy had higher odds of babies with CAs compared to mothers of controls. Similarly, maternal diseases or medical illnesses, such as syphilis, Rubella, measles, other viral infections, [52-56] and chronic diseases were reported by several researchers as known causes of CAs [14, 18, 52–59]. Many studies reported that iron folate/folic acid supplementation in the early pregnancy and before protected or reduced the occurrence of certain CAs. For example, neural defects can be reduced if a pregnant woman appropriately takes the recommended dose of iron folate/folic acid. Women who take iron folate/folic acid are less likely to have babies with CA compared to those who do not take folic acid during and before early pregnancy [14, 60–68]. Folic acid together with vitamin B12 plays a vital role in the synthesis of nucleic acid, lipids, and proteins, required for cell division. Iron folate/folic acid also has a role in amino acids metabolisms that are needed for DNA and RNA synthesis and plays an important role as an antioxidant agent. Therefore, it is essential to make it available to all pregnant women. Various studies suggested that multivitamin or folic acid containing multivitamin use during/ before pregnancy reduces/protects against some CAs [60, 65–68]. Multivitamins are essential organic substances, which are required by the body for normal body metabolic functions, body building, and controlling chemical reactions, such as converting food substances into energy and living tissues, as well as for survival or living healthy. Some components of multivitamins act as antioxidant substances (i.e. protect cells from damage by free radicals), for example, vitamin “E” and “C”. Moreover, some components of multivitamins are also important for body defense mechanisms, for instance, zinc, vitamin “C”, and vitamin “A” protect the body from diseases. As observed in this study, in Ethiopia, health care providers might not have been providing folic acid or multivitamin containing folic acid supplementation to pregnant women until recent times. However, recently the Federal Ministry of Health recommended iron folate supplementation to all pregnant women although most such women have not been provided still. Moreover, research on folic acid supplementation and knowledge of women about folic acid use during pregnancy is limited in Ethiopia. In this study, maternal age, ethnicity, sex of child, maternal education, and parity were not significantly associated with the occurrence of CAs. This finding is in agreement with that of a study conducted in Saudi Arabia by Salih et al., [18]. However, previous studies have shown a linkage to maternal age, (greater than 35) [14, 69], maternal education, and parity with the occurrence of CA [69]. In the present study, cigarette smoking and passive smoking were not associated with CAs although several researchers reported that smoking/passive smoking was associated with a specific types of CAs [32, 70–73]. In some societies, women in the reproductive age group smoke cigarettes. This may be due to cultural and personal habits. In addition, exposure to radiation had no statistically significant link in this study. Moreover, blood relationship, family history, and the Odds of having children with CA had no statistically significant associations in this study. To the contrary, other studies reported that a significant association occurred between blood relationship/family history and CA [18, 73–75]. This variation might be due to differences in the cultures of consanguinity marriage and genetic makeup. In addition, there were no associations between birth order, preterm, miscarriage, and CAs in the present study. In general, the present study indicates that the characteristics of cases and controls are closer, except for a few variations, like maternal alcohol drinking and maternal illness. In addition, our findings are in line with some previous reports and at variance with others. The reason they are different from the reports of some studies may be differences in socio-demographic, geographic, study setting, methodological, and environmental characteristics.

Conclusion

The findings of this study showed that alcohol drinking, unidentified medication use, and exposure to chemicals had significant associations with the occurrence of CAs. Iron folate use before and during pregnancy indicated a protective effect on CAs. However, current iron folate and multivitamin supplementation to pregnant women has been inadequate and infrequent because only very few women are observed using them during pregnancy, while the majority of women in the reproductive age groups are not getting prior to conception and during early pregnancy. Therefore, we emphasize that the supplementation is required to reproductive age groups, particularly around conception and during early pregnancy. Although the causes of CAs are unknown and not studied in Ethiopia, screening nutritional deficiencies, chronic diseases, such as anemia, diabetics, infections/diseases (i.e. viral infections and sexually transmitted diseases) and establishing preventive measures, for example, health education to the public, specifically to reproductive age women are very important. So, to understand and identify the risk factors for CAs, it is necessary to conduct further population based investigations in different parts of the country to further ascertain the presently observed risk factors in association with CAs, as well as fully explore factors, which are not associated with CAs.
  52 in total

1.  Risk and protective factors in the origin of conotruncal defects of heart--a population-based case-control study.

Authors:  Melinda Csáky-Szunyogh; Attila Vereczkey; Zsolt Kósa; Balázs Gerencsér; Andrew E Czeizel
Journal:  Am J Med Genet A       Date:  2013-08-15       Impact factor: 2.802

2.  Twelve-year prevalence of common neonatal congenital malformations in Zhejiang Province, China.

Authors:  Ge Sun; Zhe-Ming Xu; Jian-Feng Liang; Lin Li; Da-Xing Tang
Journal:  World J Pediatr       Date:  2011-10-20       Impact factor: 2.764

3.  Periconceptional folic acid associated with an increased risk of oral clefts relative to non-folate related malformations in the Northern Netherlands: a population based case-control study.

Authors:  Anna M Rozendaal; Anthonie J van Essen; Gerard J te Meerman; Marian K Bakker; Jan J van der Biezen; Sieneke M Goorhuis-Brouwer; Christl Vermeij-Keers; Hermien E K de Walle
Journal:  Eur J Epidemiol       Date:  2013-10-04       Impact factor: 8.082

4.  Risk of congenital anomalies near hazardous-waste landfill sites in Europe: the EUROHAZCON study.

Authors:  H Dolk; M Vrijheid; B Armstrong; L Abramsky; F Bianchi; E Garne; V Nelen; E Robert; J E Scott; D Stone; R Tenconi
Journal:  Lancet       Date:  1998-08-08       Impact factor: 79.321

5.  Pattern of congenital malformations in consanguineous versus nonconsanguineous marriages in Kashan, Islamic Republic of Iran.

Authors:  Z Mosayebi; A H Movahedian
Journal:  East Mediterr Health J       Date:  2007 Jul-Aug       Impact factor: 1.628

6.  Folate awareness and the prevalence of neural tube defects in South Australia, 1966-2007.

Authors:  Annabelle C Chan; Phillipa van Essen; Heather Scott; Eric A Haan; Leonie Sage; Joan Scott; Tiffany K Gill; Anh-Minh T Nguyen
Journal:  Med J Aust       Date:  2008-11-17       Impact factor: 7.738

Review 7.  Cumulative Chemical Exposures During Pregnancy and Early Development.

Authors:  Susanna D Mitro; Tyiesha Johnson; Ami R Zota
Journal:  Curr Environ Health Rep       Date:  2015-12

8.  Assessment of drug use among pregnant women in Addis Ababa, Ethiopia.

Authors:  Binyam Kebede; Teferi Gedif; Ashebir Getachew
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-06       Impact factor: 2.890

9.  Syphilis Infection during pregnancy: fetal risks and clinical management.

Authors:  Marco De Santis; Carmen De Luca; Ilenia Mappa; Terryann Spagnuolo; Angelo Licameli; Gianluca Straface; Giovanni Scambia
Journal:  Infect Dis Obstet Gynecol       Date:  2012-07-04

10.  Agricultural chemical exposures and birth defects in the Eastern Cape Province, South Africa: a case-control study.

Authors:  Gudrun A Heeren; Joanne Tyler; Andrew Mandeya
Journal:  Environ Health       Date:  2003-10-04       Impact factor: 5.984

View more
  14 in total

1.  Determinants and seasonality of major structural birth defects among newborns delivered at primary and referral hospital of East and West Gojjam zones, Northwest Ethiopia 2017-2018: case-control study.

Authors:  Binalfew Tsehay; Desalegn Shitie; Akilog Lake; Erimiyas Abebaw; Amisalu Taye; Enatinesh Essa
Journal:  BMC Res Notes       Date:  2019-08-09

2.  Congenital anomalies prevalence in Addis Ababa and the Amhara region, Ethiopia: a descriptive cross-sectional study.

Authors:  Molla Taye; Mekbeb Afework; Wondwossen Fantaye; Ermias Diro; Alemayehu Worku
Journal:  BMC Pediatr       Date:  2019-07-11       Impact factor: 2.125

3.  The Differences of Population Birth Defects in Epidemiology Analysis between the Rural and Urban Areas of Hunan Province in China, 2014-2018.

Authors:  Lili Xiong; Qiongying Chen; Aihua Wang; Fanjuan Kong; Donghua Xie; Zhiqun Xie
Journal:  Biomed Res Int       Date:  2021-04-21       Impact factor: 3.411

4.  Risk factors for major external structural birth defects among children in Kiambu County, Kenya: a case-control study.

Authors:  George N Agot; Marshal M Mweu; Joseph K Wang'ombe
Journal:  F1000Res       Date:  2021-02-01

5.  Congenital Anomalies and Associated Factors among Newborns in Bishoftu General Hospital, Oromia, Ethiopia: A Retrospective Study.

Authors:  Samuel Gedamu; Endalew Gemechu Sendo; Workinesh Daba
Journal:  J Environ Public Health       Date:  2021-03-31

Review 6.  The effect of substance use during pregnancy on neonatal outcomes in Ethiopia: A systematic review and meta-analysis.

Authors:  Wubet Alebachew Bayih; Demeke Mesfin Belay; Metadel Yibeltal Ayalew; Misganaw Abie Tassew; Ermiyas Sisay Chanie; Dejen Getaneh Feleke; Sintayehu Asnakew; Getasew Legas; Amsalu Belete; Maru Mekie; Getachew Yideg Yitbarek; Tigabu Munye Aytenew; Tigabu Dessie; Nigus Selomon; Solomon Demis Kebede; Tewachew Muche Liyeh; Binyam Minuye Birhanie
Journal:  Heliyon       Date:  2021-04-22

7.  Risk factors associated with congenital anomalies among newborns in southwestern Ethiopia: A case-control study.

Authors:  Soressa Abebe; Girmai Gebru; Demisew Amenu; Zeleke Mekonnen; Lemessa Dube
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

8.  Congenital anomalies among newborn babies in Felege-Hiwot Comprehensive Specialized Referral Hospital, Bahir Dar, Ethiopia.

Authors:  Daniel Mekonnen; Walelegn Worku
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

9.  Prevalence and associated factors of birth defects among newborns in sub-Saharan African countries: a systematic review and meta-analysis.

Authors:  Fentahun Adane; Mekbeb Afework; Girma Seyoum; Alemu Gebrie
Journal:  Pan Afr Med J       Date:  2020-05-14

10.  Alcohol consumption and its associated factors among pregnant women in Sub-Saharan Africa: a systematic review and meta-analysis' as given in the submission system.

Authors:  Alemu Earsido Addila; Telake Azale Bisetegn; Yigzaw Kebede Gete; Mezgebu Yitayal Mengistu; Getnet Mihretie Beyene
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.